Diffusion Pharmaceuticals Inc Stock News

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vericel (VCEL), Amarin (AMRN) and Jazz Pharmaceuticals

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vericel ( VCEL – Research Report ), Amarin ( AMRN – Research Report ) and Jazz Pharmaceuticals ( JA

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Corcept Therapeutics (CORT) today and set a price target of $18.00. The

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Corcept Therapeutics (CORT – Research Report) today and set a

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IMV (IMV

This patent relates to pharmaceutical compositions of trans sodium crocetinate (“TSC”) and a cyclodextrin for use in therapy. Specifically claimed are TSC compositions are for use in conjunction

GW Pharmaceuticals PLC undefined said Monday it has submitted a supplemental New Drug Application (NDA) to expand the label for Epidiolex cannabidiol oral...

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Clovis Oncology (CLVS), Corcept Therapeutics (CORT) and

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Clovis Oncology ( CLVS – Research Report ), Corcept Therapeutics ( CORT – Research Report ) and Ver

Facebook’s Libra Cryptocurrency Launch ‘Failed’ to launch in 2020. Libra Association formed a new and independent Technical Steering Committee (TSC).

Northern Lincolnshire Business Awards 2020 launches

If you’re on a budget, yet in a risk-tolerant mood, it’s worth taking a look at penny stocks – companies whose shares sell for less than $5 apiece. Here

Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them generate a profit in the stock

CHARLOTTESVILLE, Va., Jan. 10, 2020 -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”), a cutting-edge biotechnology company.

By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT Business Update Encouraging Data for Dose Escalation Run-in of Phase 3 GBM Trial On December 10, 2019, Diffusion Pharmaceuticals, Inc